APA (7th ed.) Citation

SJ, S., TH, H., HY, L., SW, C., LW, W., TS, C., . . . MS, W. (2026). Impact of Metabolic Associated Steatotic Liver Disease on Antiviral Therapy Outcomes on Chronic Hepatitis B Patients Receiving Antiviral Therapy. Journal of medical virology, 98(3), e70864. https://doi.org/10.1002/jmv.70864

Chicago Style (17th ed.) Citation

SJ, Shiue, et al. "Impact of Metabolic Associated Steatotic Liver Disease on Antiviral Therapy Outcomes on Chronic Hepatitis B Patients Receiving Antiviral Therapy." Journal of Medical Virology 98, no. 3 (2026): e70864. https://doi.org/10.1002/jmv.70864.

MLA (9th ed.) Citation

SJ, Shiue, et al. "Impact of Metabolic Associated Steatotic Liver Disease on Antiviral Therapy Outcomes on Chronic Hepatitis B Patients Receiving Antiviral Therapy." Journal of Medical Virology, vol. 98, no. 3, 2026, p. e70864, https://doi.org/10.1002/jmv.70864.